ADVANDX, INC.

Profile

Company Names

ADVANDX, INC.

Addresses

400 TRADECENTER, SUITE 6990, WOBURN, MA 01801

Phone Numbers

1-866-376-0009

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$13,741,732.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-02-27 
$2,500,000.00 
$2,500,000.00 
$0.00 
Debt 
2
2014-03-31 
$9,074,963.00 
$12,075,000.00 
$3,000,037.00 
Equity 
1
2012-10-12 
$2,166,769.00 
$6,138,348.00 
$3,971,579.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HANS 
 
ANDREASSON 
DIRECTOR
ADVANDX, INC.   |  GOLDCUP 12446 AB
THIERRY 
 
BERNARD 
DIRECTOR
DAKTARI DIAGNOSTICS, INC.   |  ADVANDX, INC.   |  FIRST LIGHT BIOSCIENCES INC.
JAMES 
M. 
COULL 
EXECUTIVE OFFICER
ADVANDX, INC.
HEINER 
 
DREISMANN 
DIRECTOR
GENENEWS LTD   |  STRATOS GENOMICS INC.   |  SINGULEX INC   |  HISTORX INC   |  SINGULEX, INC.   |  ADARZA BIOSYSTEMS, INC.   |  ADVANDX, INC.   |  GESTVISION, INC.   |  IXCELA, INC.   |  MOBILION SYSTEMS, INC.   |  MAINZ BIOMED N.V.
CHRISTOPHER 
D. 
EARL 
DIRECTOR
ADVANDX, INC.
ROGER 
D. 
GRAHAM, JR. 
EXECUTIVE OFFICER
ADVANDX, INC.
DONALD 
B. 
HAWTHORNE 
EXECUTIVE OFFICER
ADVANDX, INC.
THOMAS 
P. 
KELLY 
EXECUTIVE OFFICER
ADVANDX, INC.   |  APFC HCF HOLDINGS REIT LLC   |  HHF STORAGE 106 INVESTOR, LLC   |  HVP VI CO-INVESTOR 1 REIT LLC
DENNIS 
H. 
LANGER 
EXECUTIVE OFFICER, DIRECTOR
DICERNA PHARMACEUTICALS INC   |  ADVANDX, INC.   |  QUOIN PHARMACEUTICALS, INC.
DAVID 
M. 
RUBIN 
DIRECTOR
ADVANDX, INC.
INGELISE 
 
SAUNDERS 
DIRECTOR
ADVANDX, INC.
LARS 
 
TONNESEN 
DIRECTOR
ADVANDX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-03-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-02-27 
2014-04-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-31 
2012-10-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#